Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a cytokine belonging to the TNF superfamily, is regarded as a mediator of neurotoxicity. The constitutively expressed ion exchanger Na + /Ca 2+ exchanger isoform-3 (NCX3) has been shown to protect neurons from injury. Its expression is induced by nerve growth factor (NGF) through activation of its tyrosine kinase receptor trkA. The latter, in turn, activates downstream kinases, such as extracellular signal-regulated kinase (ERK) and the survival-related kinase protein kinase B (AKT). Here, we verified whether TRAIL could influence the expression of NCX3 via modulation of the NGF/trkA system. Differentiated human neuroblastoma SH-SY5Y cells were incubated with TRAIL and, subsequently, the expression of the NCX3 protein was studied at different times by means of western blot analysis. Then, the expression of the phosphorylated forms of either trkA, ERK or AKT was analyzed at identical intervals. Western blot analysis revealed that the expression of NCX3 protein decreased in a time-dependent fashion in SH-SY5Y cells treated with TRAIL, to reach its minimum at 48 h. On the other hand, p-trkA, p-ERK, and p-AKT expression was increased in cells treated with TRAIL after 6 and 16 h; then it declined to nearly undetectable levels after 48 h. Results indicate that the increase in TRAIL expression occurring during neuronal damage may be responsible of NCX3 down-regulation and weakens its neuroprotective effects. The TRAIL system could thus represent a potential target for treatment of neuronal damage characterized by NCX3 function impairment.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a cytokine belonging to the TNF superfamily, is regarded as a mediator of neurotoxicity. The constitutively expressed ion exchanger Na + /Ca 2+ exchanger isoform-3 (NCX3) has been shown to protect neurons from injury. Its expression is induced by nerve growth factor (NGF) through activation of its tyrosine kinase receptor trkA. The latter, in turn, activates downstream kinases, such as extracellular signal-regulated kinase (ERK) and the survival-related kinase protein kinase B (AKT). Here, we verified whether TRAIL could influence the expression of NCX3 via modulation of the NGF/trkA system. Differentiated human neuroblastoma SH-SY5Y cells were incubated with TRAIL and, subsequently, the expression of the NCX3 protein was studied at different times by means of western blot analysis. Then, the expression of the phosphorylated forms of either trkA, ERK or AKT was analyzed at identical intervals. Western blot analysis revealed that the expression of NCX3 protein decreased in a time-dependent fashion in SH-SY5Y cells treated with TRAIL, to reach its minimum at 48 h. On the other hand, p-trkA, p-ERK, and p-AKT expression was increased in cells treated with TRAIL after 6 and 16 h; then it declined to nearly undetectable levels after 48 h. Results indicate that the increase in TRAIL expression occurring during neuronal damage may be responsible of NCX3 down-regulation and weakens its neuroprotective effects. The TRAIL system could thus represent a potential target for treatment of neuronal damage characterized by NCX3 function impairment.
Introduction
Although neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease, and others have been extensively studied [1] [2] [3] , the mechanisms governing the extent of vulnerability to such conditions still remain widely unclear [4] . Convincing evidence supports the pathophysiologic relevance of exchanger; NGF, nerve growth factor; PI, propidium iodide; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; TrkA, tyrosine kinase receptor A.
inflammatory mediators, also expressed by injured neurons during neurodegenerative processes. In this line, proinflammatory cytokines have been shown to substantially contribute to the neuroinflammatory scenario set into motion in course of neurodegeneration [5] . In fact, increased levels of inflammatory molecules, such as TNF-a, IL-1b, nitric oxide, and others are increased in the brain with prominent neuronal death [6, 7] . In particular, proapoptotic/proinflammatory cytokines belonging to the tumor necrosis factor superfamily are regarded as potent sustainers of neurodegenerative processes in the CNS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, efficiently promotes cell death and plays a prominent role in the systemic inflammatory/immune response [8] [9] [10] . By binding its DR4 and DR5 receptors, TRAIL modulates different intracellular pathways, including mitogen-activated protein kinases (MAPKs), protein kinase B (PKB/ AKT), and the NFkB signaling cascade [11] , as well as c-Jun N-terminal protein kinase (JNK) [12] , and depending upon the cellular system it can control cell death and/or survival.
Tumor necrosis factor-related apoptosis-inducing ligand is a potent mediator of neuronal death induced in both chronic and acute neurodegenerative processes, as it is involved, for example, in amyloid neurotoxicity [10, 13] , brain ischemia [14, 15] , and trauma-related neuronal injury [16] , conditions in which it amplifies neuroinflammatory processes [17] . In fact, expression of TRAIL is increased in all these conditions, and associated with caspase activation, gliosis, and overexpression of an array of proinflammatory mediators [18] . Consistently, immunoneutralization of TRAIL results in decreased amyloid-b accumulation in the brain of 3xTg-AD mouse and reduced cognitive decline [19] .
Control of intracellular calcium signaling is essential to neuronal function [20] . Maintenance of cell Ca 2+ homeostasis depends upon specific transport systems that remove calcium from the cytosol [21] . Na + /Ca 2+ exchange is the main calcium export mechanism across the plasma membranes that reconstitutes resting levels of calcium in neurons after stimulation [22] . The Na + /Ca 2+ exchanger (NCX) is a membrane ion transporter that can work in both forward (Ca 2+ extrusion coupled with Na + influx) and reverse (Ca 2+ entry in exchange for Na + extrusion) modes [23] . To date, three mammalian NCX isoforms have been identified, namely, the ubiquitous NCX1, as well as NCX2 and NCX3, which are almost exclusive to the brain and the skeletal muscle. In physiological conditions, neuronal NCX-mediated Ca 2+ extrusion is primarily involved in maintaining Ca 2+ homeostasis, while NCX forward activity can also play a neuroprotective role by restoring cell Ca 2+ levels depleted, for instance, by ischemia and excitotoxicity [24, 25] . In contrast, in extremely severe brain injury, energetic failure and intracellular Na + elevation incite Ca 2+ entry via NCX, which ultimately contributes to Ca 2+ overload [24] . NCX1 and NCX3, two of the three brain isoforms of the plasma membrane NCX, are targets of the phosphatidylinositol 3-kinase/AKT pathway [26] , which is largely recognized as a relevant pathway in regulating neuronal survival [27] . In fact, phosphatidylinositol 3-kinase/AKT is able to control different cell functions such as glucose metabolism, mitochondrial death pathway, CREB phosphorylation, and others [28] . In addition, it has been shown that PI3K/AKT is able to mediate nerve growth factor (NGF) effects on neurite outgrowth in neural cells [29] and that NGF is, in turn, able to induce an up-regulation of NCX1 and NCX3 expression, while it down-regulates NCX2 [26] . NGF is a neurotrophin with prominent neuroprotective effects which works as a main biological driver of neuron development, survival, and differentiation, either in the central or in the peripheral nervous system [30] . Binding of NGF to its tyrosine kinase receptor A (TrkA) results in the autophosphorylation of the tyrosine residues on the cytoplasmic domain and the activation of related downstream signaling elements, including the MAPK cascade and the protein kinase C [31] as well as the PI3K/AKT pathway [32] .
In light of these data, we focused our attention on a possible relationship between the antagonistic effects of TRAIL and NGF on neuronal functions through modulation of NCX proteins. To do so, we studied possible interactions and related molecular mechanisms among TRAIL, NCX3, and NGF in cultures of differentiated SH-SY5Y human neuroblastoma, a cell line originally derived from a metastatic bone tumor biopsy that can be differentiated to a more mature neuron-like phenotype characterized by neuronal markers [33] .
Results
NCX1 and NCX3 expression in the differentiated SH-SY5Y human neuroblastoma cells NCX1 and NCX3 isoforms are involved in cell survival and protection mechanisms [34, 35] . However, the two different isoforms may be differentially expressed. In order to understand the role of both NCX1 and -3, we analyzed both mRNA levels and protein expression in lysates from either untreated or differentiated (at different times) with retinoic acid SH-SY5Y human neuroblastoma cells cultured in vitro. Results indicate that both NCX1 and NCX3 mRNAs are expressed and their respective levels do not change at different times of differentiation with retinoic acid (Fig. 1, panel A) .
Western blot experiments showed that, while the expression of the NCX1 isoform was present in the undifferentiated cells, it disappeared in differentiated cells. On the other hand, the expression of the NCX3 isoform of the NCX protein increased in SH-SY5Y human neuroblastoma cells in a time-dependent fashion as the differentiation proceeded, showing levels increasing in a time-dependent manner. (Fig. 1, panel B) .
Immunofluorescence data of NCX1 and NCX3 were consistent with western blot results (Fig. 1, panel C) .
TRAIL treatment decreases NCX3 protein expression in differentiated SH-SY5Y cells
To explore the mechanism of TRAIL toxicity [11] and assess the role of NCX3, we first investigated whether treatment with TRAIL could modulate at different times either mRNA levels or the expression of the NCX3 protein in differentiated SH-SY5Y cells. RT-PCR showed that no variations occurred in NCX3 mRNA levels over time (Fig. 2, panel A) . On the other hand, western blot analysis of whole lysates from cells treated with TRAIL showed that NCX3 protein levels were significantly decreased in a time-dependent manner, and the reduction in NCX3 protein expression was statistically significant already at 6 h, reaching a maximum at 48 h after exposure to TRAIL, as assessed by the following densitometric analysis (Fig. 2, panel B) . TRAIL modulates expression of NGF, TrkA, as well as downstream signal transduction in differentiated SH-SY5Y cells
As it is known that NGF induces an up-regulation of NCX3 expression [36] , we tested whether the effect of TRAIL on NCX3 could depend on NGF expression. Western blot analysis of the NGF protein in SH-SY5Y cells treated with TRAIL showed that TRAIL is able to modulate the expression of the NGF. In fact, TRAIL induced the expression of NGF after 6 h of incubation, reaching its peak at 16 h, whereas it inhibited its expression thereafter (Fig. 3, panel A) .
Moreover, with the aim to explore whether TRAIL could affect NGF TrkA receptor and its downstream pathway, we investigate the expression of TrkA, as well as its phosphorylation and some related downstream signaling molecules, such as MAPK, JNK-1, and p-38 kinases in SH-SY5Y cells treated with TRAIL. Western blot analysis of TrkA showed that TRAIL did not affect TrkA constitutive expression, while it significantly affected its phosphorylation. In fact, TRAIL induced phosphorylation of TrkA at 6 and 16 h, followed by an inhibition of TrkA phosphorylation, an effect which paralleled the levels of NGF expression (Fig. 3, panel B) .
Downstream signaling triggered by TrkA receptor encompasses the activation of protein kinase such as MAPK and AKT. Accordingly, TRAIL-induced TrkA phosphorylation in SH-SY5Y cells was associated with a significant increase in extracellular signal-regulated kinase (ERK) phosphorylation that reached a peak at 6 h to decrease thereafter, whereas AKT phosphorylation started at 6 h, reached the maximum at 16 h and then decreased (Fig. 4) . Finally, to better elucidate the signaling events occurring after activation of TrkA receptor, we also analyzed the expression of JNK-1 and p-38 in SH-SY5Y cells treated with TRAIL. Western blot analysis showed that JNK-1 is phosphorylated after 6 up to 48 h of treatment, whereas p-38 resulted phosphorylated after 24 up to 48 h (Fig. 4) .
NGF restores NCX3 expression inhibited by TRAIL
To further confirm the hypothesis that the inhibitory effect of TRAIL upon NCX3 depends on the NGF expression, SH-SY5Y cells were treated for 24 with either TRAIL or NGF alone, or with their combination. Western blot analysis demonstrated that TRAIL was able to inhibit NCX3 expression, whereas NGF treatment did not exert significant additive effect compared to untreated SH-SY5Y cells. Moreover, cells treated with the combination of the two substances showed a NCX3 expression significantly lower than control cultures, and higher than cultures treated with TRAIL, suggesting that NGF restores NCX3 expression inhibited by TRAIL in SH-SY5Y cells (Fig. 5,  panel A) .
Immunofluorescence data related to NCX3 were consistent with western blot results and, additionally, indicated that TRAIL inhibits the expression of both NCX3 and p-TrkA, and that treatment with NGF was significance was set at a P-value < 0.05 (one-way ANOVA followed by Fisher's LSD test). CTRL: untreated control cells.
able to restore their expression in cells treated with TRAIL. In cells treated with NGF, p-TrkA and NCX3 expression was colocalized (Fig. 5, panel B) .
NGF rescues SH-SY5Y cells from TRAIL-mediated cell death
In order to demonstrate the role of NGF in protecting cells from TRAIL toxicity, we first performed immunofluorescence experiments which showed that the addition of NGF to cultured SH-SY5Y cells resulted in a significantly diminished expression of apoptosisrelated fluorescence (Fig. 6, panel A) . Subsequently, to better assess neuroprotective effects of NGF, SH-SY5Y cells, treated with the NCX3 siRNA, were challenged with TRAIL, either in the presence or in the absence of different concentrations of NGF. A control of the efficacy of NCX3 silencing was performed and illustrated in Fig. 6 (panel B) .
When cells were treated with NCX3 siRNA, we definitely observed significantly reduced viability. Nevertheless, in NCX3 silenced cells treated with toxic concentrations of TRAIL (100 ngÁmL À1 ) a further reduced viability was observed. Significantly higher viability indexes were observed after 48 h in SH-SY5Y cells treated with NGF, at all the concentrations used (Fig. 6, panel C) .
The inhibitory effect of TRAIL on NCX reverse mode is significantly suppressed by NGF
To determine whether alterations in plasma membrane Na + /Ca 2+ activity mirrored the inhibitory effect of TRAIL on NCX3 expression, we analyzed NCX function in FLUO-4-loaded SH-SY5Y cells, subjected to extracellular Na + removal as described before [37] . After 60 s of basal fluorescence monitoring, NCX-mediated [Ca 2+ ] uptake was enhanced with a sodium-free stimulus, and the exchange reverse mode activity was measured as Δ% increase (Fig. 7, panel A) , (see Materials and methods for further details). In the control Vertical bars are means AE SEM of at least three different experiments; significance was set at a P-value < 0.05 (one-way ANOVA followed by Fisher's LSD test). (Panel B) Immunofluorescence of NCX3 (green) and p-TrkA (red) after 48 h treatment with either TRAIL alone, NGF alone or the combination of the two substances (merge column; DAPI = nuclear staining). Scale bars = 10 lm.
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The ]i; reflecting Ca 2+ influx through the reverse mode of NCX) and the fluorescence signal increased on average by 260% over basal level (Fig. 7, panel B) . When SH-SY5Y cells were exposed to TRAIL, NCX activity was significantly reduced (20% less) as compared to control groups. Strikingly, the inhibitory effect of TRAIL on NCX reverse mode was completely suppressed by NGF. As summarized in Fig. 7 , no differences were observed comparing controls with NGF-treated cells. Overall, these results are consistent with those represented in Fig. 5 .
Discussion
Here, we show that TRAIL is able to exert its detrimental effects upon the neuronal-like cell line SH-SY5Y by modulating the expression of the neuroprotective Na modulation of NGF expression and its receptors. In a first set of experiments we observed in fact that, mRNA of both NCX isoforms NCX1 and NCX3 was present either before or after differentiation of SH-SY5Y human neuroblastoma cells. On the other hand, western blot experiments showed that, while NCX1 was expressed in undifferentiated and disappeared in the differentiated cultures, the expression of the NCX3 isoform, very attenuated in the undifferentiated cultures, was significantly increased in the differentiated SH-SY5Y cells. From these observations it can be assumed that mRNA and proteins of the two NCX isoforms are differentially regulated and expressed, as, possibly, posttranscriptional mechanisms are involved [38] . Thus, as the NCX3 was the only isoform significantly expressed in differentiated SH-SY5Y cells, we focused on the effects of TRAIL upon the NCX3 isoform expression and function. After TRAIL treatment, while NCX3 mRNA was invariated, western blot of cells treated with TRAIL revealed a time-dependent decrease in NCX3 expression. We could speculate that such an effect of TRAIL may be dependent upon NCX3 post-transductional regulation. Moreover, it has been shown that NCX3 expression may be modulated also by NGF a neurotrophin-affecting development of neurons, and their survival, and differentiation in the central and the peripheral nervous systems [26] . For this reason, we verified whether the effect of TRAIL on NCX3 could depend also on the expression of NGF. Indeed, the expression of the latter in SH-SY5Y cells that had undergone TRAIL treatment initially increased, while dramatically decreasing thereafter. Such an initial increase in NGF expression appears in line with a general mechanism of self-protection that neurons set into motion in the attempt to counteract exposure to an injury. In fact, it has been widely demonstrated that injured cells promptly increase the expression of factors related with cell survival and proliferation [39] [40] [41] [42] , a mechanism that progressively weakens when the application of the noxious stimulus is persistent [43] . The negative effects of TRAIL on NGF expression were paralleled by decreased phosphorylation of its main effector, the TrkA receptor. This phenomenon appeared as a consequence of the diminished NGF amount [44] [45] [46] and was reflected also by the initially increased, finally decreased phosphorylation of TrkA downstream kinase, such as ERK and AKT. It has been reported that both ERK and AKT expression and their functional status are activated during the application of detrimental stimuli to cells, including biological [47] chemical [48] , or physical [49, 50] factors. JNK-1 and p-38 kinases are in turn activated to promote cell damage and eventual cell death under the effects of toxic molecules [51] . Their activation is in fact associated with morphologic 400, 440, 380, and 400 in CTRL, TRAIL, NGF + TRAIL, and NGF groups. Cells were treated as described and recorded in five different experimental sessions. Differences among means were assessed by one-way ANOVA followed by Dunnet's post hoc test.**P < 0.01 and ***P < 0.001.
changes [52] and, eventually, with increased cell death rate [53] . In this line, incubation of SH-SY5Y cells with TRAIL, resulted in fact in the increase of phosphorylation of the two kinases JNK-1 and p38, which are activated in response to different cell stress stimuli [54] [55] [56] and participate in pathways related with cell impairment [52] and apoptosis [57] . In addition, TRAIL negatively competes with NGF in the PI3K/AKT signaling pathway, as well as in the MAPK pathway [11] . Our results also demonstrate the efficacy of exogenously administrated NGF against TRAIL-mediated cell death and suggest a role for NCX3 in such a protective effect. In particular, the protein decline of NCX3 induced by TRAIL, functionally correlates with a significant reduction in plasma membrane exchange activity, whereas NGF-dependent neuroprotection appears to be parallel with the normalization of NCX3 expression and the recovery of the NCX3 function to control levels. In fact, previous in vitro and in vivo studies have documented that when NCX3 levels are reduced neurons are less capable of managing calcium (and sodium) homeostasis and, thereby, are more vulnerable to stressful conditions such as exposure to amyloid-b peptide [58] , excitotoxicity [25] , or ischemia [34] .
In conclusion, these results show that TRAIL abundantly produced in the CNS in course of neuronal injury/damage may be responsible for NCX3 down-regulation and diminished neuroprotective potential, so contributing to the neurotoxic effect of the cytokine.
The TRAIL system could thus represent a possible target for the treatment of neural damage characterized by NCX3 function impairment in neurodegenerative disorders.
Materials and methods

Drugs and reagents
Tumor necrosis factor-related apoptosis-inducing ligand was purchased from Alexis Biochemicals (San Diego, CA, USA). Human recombinant NGF-beta was obtained from Alomone Labs, Ltd. (Jerusalem, Israel). Media, media supplements, serum, trypsin, and antibiotics, were from Invitrogen Srl (Milan, Italy). Cell culture plastics were provided by BD Falcon (Milano, Italy).
Cell cultures
The human neuroblastoma cell line SH-SY5Y was obtained from American Type Culture Collection (ATCC, Manassas VA, USA) and grown in 1 : All measurements were performed in triplicate and the comparative Ct method was used to calculate relative mRNA expression. Ct values of both the calibrator and the samples of interest were normalized to HPRT. The comparative Ct method is also known as the 2DDCt method, where, DDCt = DCt sample À DCt reference. DCT, sample is the Ct value for the samples normalized to the endogenous housekeeping gene, and DCt reference is the Ct value for the calibrator, also normalized to the endogenous housekeeping gene.
Western blot analysis
Cells were harvested in a lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 100 mM NaF, 1 mM PMSF, and protease inhibitor cocktail; Sigma-Aldrich). After centrifugation at 10 518 g at 4°C for 20 min, the supernatants were collected. Protein concentration was estimated using the Bradford reagent (Bio-Rad Laboratories, Segrate, Italy). Then, 30 lg of protein was mixed with the Laemmli sample buffer and boiled at 95°C for 5 min. The samples were resolved by 8-12% SDS/PAGE and transferred to Hybond-enhanced chemiluminescence (ECL) nitrocellulose membranes (GE Healthcare, Little Chalfont, UK). Blots were blocked for 60 min at room temperature with a blocking solution composed of 5% nonfat dry milk (Bio-Rad Laboratories) in PBS plus 0.1% Tween 20 and were then probed with the appropriate primary antibodies: a mouse anti-NCX1 monoclonal antibody (Swant, Bellinzona, Switzerland), or a rabbit anti-NCX3 polyclonal antibody (Swant), or a rabbit anti-NGF monoclonal antibody (Santa Cruz Biotechnology, Inc., Dallas, TX; USA), or a rabbit anti-TrkA polyclonal antibody (Santa Cruz Biotechnology, Inc.), or a mouse anti-p-TrkA monoclonal antibody (Santa Cruz Biotechnology, Inc.), or a rabbit anti-p-AKT polyclonal antibody (Cell Signaling Technology, Danvers, MA, USA), or a rabbit anti-p-ERK1/2 polyclonal antibody (Cell Signaling Technology), or a mouse anti-p-JNK monoclonal antibody (Santa Cruz Biotechnology, Inc.), or a rabbit anti-P-p38 monoclonal antibody (Cell Signaling Technology). After that the membranes were washed with PBS with 0.1% Tween, and finally were probed with the appropriate horseradish peroxidase-conjugated secondary antibodies (GE Healthcare; 1 : 10 000; for 60 min at room temperature in 5% nonfat dry milk). For immunodetection the membranes were exposed to film after ECL (GE Healthcare). b-tubulin (Santa Cruz Biotechnology) was used as an internal control to validate the right amount of protein loaded on the gels. Densitometric analysis of band intensity was performed with the aid of IMAGEJ software (https://ima gej.nih.gov/ij/). 
NCX3 silencing
Silencing of NCX3 in SH-SY5Y-differentiated cells was performed by using the HiPerFect Transfection kit (Qiagen), by using FlexiTube siRNA for NCX3, (#8) Hs_Slc8A3_8 (5 0 -CACCACGCTCTTGCTTCCTAA-3 0 ), and a validated irrelevant AllStars siRNA as a negative control. Cells were incubated with OptiMEM (Invitrogen) supplemented with the RNAiFect transfection reagent (Qiagen) and 20 nM of each siRNA duplex for 6 h.
Cell viability analysis
Cell viability was determined by 3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (Sigma-Aldrich) assay. Briefly, SH-SY5Y-differentiated cells were plated on 96-well cultured plates at a density of 5 9 10 3 cells per well. After the 48-h treatment, cell viability was measured by the reduction of 3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide solution (0.5 mgÁmL À1 ). After 3 h of incubation at 37°C, this solution was removed, and produced blue formazan crystals which were solubilized in dimethylsulfoxide. The optical density of the formed blue formazan was measured at 545 nm for each well and the absorbance at 630 nm (background absorbance) was subtracted.
Intravital staining of the culture
After the experimental procedures, SH-SY5Y cells were washed with the standard buffer and stained for 3 min at 22°C with a solution containing 36 lM fluorescein diacetate (FDA; Sigma-Aldrich) and 7 lM propidium iodide (PI; Calbiochem, San Diego, CA, USA). The stained cells were examined with a standard epi-illumination fluorescence microscope. FDA, a nonpolar ester, crosses the cell membrane and is hydrolyzed by intracellular esterases to produce a green fluorescence. Cell injury curtails FDA staining and allows cell permeation with PI, a polar compound which, by interacting with nuclear DNA, yields a bright red fluorescence [59] .
Analysis of NCX activity
Ca-PSS contained (in mM) 140 NaCl, 5 KCl, 1 MgCl 2 , 10 glucose, 2 CaCl 2 , and 20 HEPES, buffered to pH 7.4 with Tris. Na-PSS had an identical composition except that calcium was omitted and 0.1 mM EGTA was included. K-PSS contained (in mM) 145KCl, 1 MgCl 2 , 10 glucose, 0.1 CaCl 2 , and 20 mM HEPES, buffered to pH 7.4 with Tris. [Ca 2+ ]i was measured by single-cell computer-assisted videoimaging using a LSM 510 confocal system (Carl Zeiss, Milan, Italy) [37] . Briefly, SH-SY5Y were differentiated on a 25-mm coverslip and then loaded with 4 lM Fluo-4/AM (Molecular Probe, Eugene, OR, USA) in Ca-PSS 0.08% pluronic acid (Molecular Probe) for 40 min in the dark at room temperature. Coverslips were then washed once in Na-PSS and treated for 10 min with 1 lM thapsigargin in Na-PSS. After an additional wash, coverslips were placed into a perfusion chamber mounted onto the stage of an inverted Zeiss Axiovert 200 microscope. NCX3 activity was evaluated as Ca 2+ uptake through the reverse mode by switching Na-PSS to K-PSS. Bath solutions were changed with a peristaltic pump and images were acquired every 5 s. Cells and perfusion solutions were maintained at 37°C by using a heated microscope stage and climate boxe from PeCon GmbH (Erbach, Baden-W€ urttemberg Germany).
Excitation light was provided by an argon laser at 488 nm and the emission was time-lapse recorded at 505-530 nm. Analysis of fluorescence intensity was performed offline after images acquisition, by averaging the fluorescence intensity values within selected areas overlying the cell somata as described before [60, 61] .
Statistical analysis of results
All the experiments were repeated at least three times. Results were analyzed by the one-way ANOVA, followed by the Fisher's Least Significant Difference test or by Dunnet's post hoc test where indicated. The criterion for statistical significance was indicated as follows *P < 0.05,°P < 0.05, # P < 0.05, **P < 0.01, and ***P < 0.001.
